Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Fungal and Parasitic Infections

Mild Plasmodium falciparum Malaria following an Episode of Severe Malaria Is Associated with Induction of the Interferon Pathway in Malawian Children

Malkie Krupka, Karl Seydel, Catherine M. Feintuch, Kenny Yee, Ryung Kim, Chang-Yun Lin, R. Brent Calder, Christine Petersen, Terrie Taylor, Johanna Daily
J. H. Adams, Editor
Malkie Krupka
aDepartments of Medicine (Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Seydel
bDepartment of Internal Medicine, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA
cBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine M. Feintuch
dDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenny Yee
eDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryung Kim
eDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang-Yun Lin
eDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Brent Calder
fDepartment of Genetics, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Petersen
gImmunobiology Program and Department of Pathology, Iowa State University, College of Veterinary Medicine, Ames, Iowa, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terrie Taylor
bDepartment of Internal Medicine, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA
cBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Daily
aDepartments of Medicine (Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
dDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. H. Adams
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.06008-11
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Infection with Plasmodium falciparum can lead to a range of severe to minimal symptoms, occasionally resulting in death in young children or nonimmune adults. In areas of high transmission, older children and adults generally suffer only mild or asymptomatic malaria infections and rarely develop severe disease. The immune features underlying this apparent immunity to severe disease remain elusive. To gain insight into host responses associated with severe and mild malaria, we conducted a longitudinal study of five children who first presented with severe malaria and, 1 month later, with mild malaria. Employing peripheral blood whole-genome profiling, we identified 68 genes that were associated with mild malaria compared to their expression in the severe malaria episode (paired Students t test, P < 0.05). These genes reflect the interferon (IFN) pathway and T cell biology and include IFN-induced protein transcripts 1 to 3, oligoadenylate synthetases 1 and 3, and the T cell markers cathepsin W and perforin. Gene set enrichment analysis identified Gene Ontology (GO) pathways associated with mild malaria to include the type I interferon-mediated signaling pathway (GO 0060337), T cell activation (GO 0042110), and other GO pathways representing many aspects of immune activation. In contrast, only six genes were associated with severe malaria, including thymidine kinase 1, which was recently found to be a biomarker of cerebral malaria susceptibility in the murine model, and carbonic anhydrase, reflecting the blood's abnormal acid base environment during severe disease. These data may provide potential insights to inform pathogenesis models and the development of therapeutics to reduce severe disease outcomes due to P. falciparum infection.

INTRODUCTION

Malaria is a leading cause of morbidity and mortality in children worldwide. Globally, over 3 billion people are at risk of acquiring malaria, and an estimated 250 million people become clinically symptomatic each year (8). Most of the 1 million deaths caused by Plasmodium falciparum occur in patients with a severe disease syndrome, which may include severe anemia, cerebral malaria (CM), respiratory distress, renal impairment, hypoglycemia, or hyperlactemia (42). Long-term complications can also occur after recovery from severe disease. A decreased language ability and vocabulary and increased likelihood of developing epilepsy and disruptive behavioral disorders have been documented in children who survived CM (7). The risk of severe disease and clinical symptoms declines as children in regions of endemicity grow older in a setting where they experience continuing exposure to infectious mosquito bites (2, 9). Thus, older malaria-infected residents in a region of P. falciparum endemicity experience only mild symptoms or are asymptomatic. The underlying mechanisms of protection from severe disease in human infections remain unclear (32). Defining the components of naturally acquired immunity to severe disease could inform vaccine development strategies and therapeutic interventions.

Blood transcriptional profiling has been used to elucidate host responses in HIV, adenovirus, bacterial, tuberculosis (TB), and other infections to build pathogenesis and predictive models (5, 24, 26, 38). Thus, we set out to delineate the differences in host transcriptional responses between episodes of severe malaria and mild malarial infection in the same individual. We compared the transcriptomes of host peripheral blood cells collected during an episode of severe malaria and, 1 month later, during a subsequent mild malaria infection in five Malawian children. Our analysis identified genes and gene sets that were significantly associated with mild malaria compared to their expression in cases of severe malaria. Our data suggest that the interferon (IFN) pathway and T cells may have important roles in the development of protective immune responses in Malawian children who had survived severe malaria. We have also identified genes associated with severe disease that could be further tested as biomarkers. These data provide insights into host peripheral blood transcriptional correlates associated with severe malaria and the subsequent development of mild clinical disease.

MATERIALS AND METHODS

Study cohort.To identify children who sustained severe malaria and a subsequent mild malaria infection, we carried out a longitudinal study of children enrolled in the Blantyre Malaria Research Project, Blantyre, Malawi, during the transmission season from January to April 2009. This study enrolls children with severe malaria to define the clinico-pathological features of CM (6, 13). Institutional review board (IRB) approvals were obtained from the Albert Einstein College of Medicine, Michigan State University, and The University of Malawi College of Medicine Research and Ethics Committee. Children between the ages of 6 months and 12 years with peripheral blood parasitemia and a Blantyre coma score of <3 were enrolled into the Blantyre malaria research ward after parental consent. At the time of admission, a blood sample was taken, and from this 3 ml was aliquoted into Tri-Reagent BD (Molecular Research Center), shaken vigorously for 15 s, and frozen at −80°C for transcriptional analyses of severe malaria. Admission data included a full physical exam, a fundoscopic exam for determination of malarial retinopathy, a complete blood count, glucose and lactate analysis, blood culture, and parasitemia count (37). Bacterial meningitis as a cause of coma was ruled out through analysis of cerebral spinal fluid bacterial culture, microscopy, and white cell count.

Study patients were followed up 1 month after discharge, at which time a thick blood smear was prepared, and a physical exam was performed including measurement of body temperature. Patients with a positive smear at this visit were sampled again by venipuncture to obtain 3 ml of whole blood that was processed for transcriptional analysis as above, and this sample comprised the episode of mild malaria. Peripheral parasite load was determined on a thick smear using the semiquantitative method; scoring was as follows: 2+ represents 11 to 100 parasites per 100 high-powered fields (HPF), 3+ represents 1 to 10 parasites per HPF, and 4+ represents >10 parasites per HPF.

RNA isolation and data analysis.The samples were shipped to New York in nitrogen gas and thawed at room temperature, and total RNA was isolated according to the manufacturer's protocol (Tri-Reagent BD; Molecular Research Center). High-quality RNA samples with an A260/A280 ratio of >1.6 and with distinct ribosomal bands on ethidium bromide-stained agarose gels were subsequently hybridized to Affymetrix GeneChip Standard 1.0 ST Arrays. Gene expression values were calculated from Affymetrix microarray probe-level data using the robust multiarray average (RMA) procedure, resulting in 32,321 probe sets which were then quantile normalized (28). The data were thresholded to a minimum of 20 expression units (EU) and a maximum of 20,000 EU. A filtered gene list of 3,110 genes was generated by removing genes that varied less than 3-fold or 100 EU in at least one sample across the 10-sample data set. Differentially abundant transcripts between the severe and mild clinical states for each paired sample were identified using a paired Student t test of log2-transformed data. To identify gene sets that were associated with each state, a library of Gene Ontology (GO) functions containing 15 to 500 genes was constructed from the Bioconductor library (accessed 4 September 2010) using all parent and child nodes. Gene sets with all evidence codes except IC, for inferred by curator, or ND, for no evidence, were included. Differentially regulated GO gene sets were identified using gene set enrichment analysis (GSEA) against a ranked list of genes containing the paired Student t test statistic of log2-transformed data (35). A weighted enrichment statistic was employed.

Microarray data accession number.All microarray data were deposited in the Gene Expression Omnibus (GEO) database under accession number GSE33811.

RESULTS

Patients (n = 119) were admitted to the Blantyre Malaria Research Project with CM or CM/severe anemia in the 2009 transmission season. All patients received intravenous quinine and routine clinical care.

Patients were documented to become smear negative during the hospital admission. Eighteen patients died, and the rest improved clinically and were discharged. Of the 101 survivors, 81% (n = 82) presented for the routine 1-month follow-up study visit. At this time 10% of these patients (n = 8) had a positive blood smear for parasites. None of the eight infected patients exhibited evidence of severe disease. A second blood draw was collected from six patients at this second time point. Five severe/mild paired samples had sufficiently high-quality RNA for microarray and further analysis.

The exam and laboratory results of five children with severe and mild malaria are shown in Table 1. These children ranged from 8 to 45 months of age, and all presented with fever on admission. Upon admission to the study, they displayed many manifestations of severe malarial disease, with all patients manifesting WHO-defined CM; four out of five had severe anemia (hematocrit of <15%), and four of the five had hyperlactemia (>10 mmol/liter). Four of five patients had evidence of retinopathy, suggestive of parasite brain sequestration (37). White blood cell counts varied from 8,100 to 75,390 cells/μl, and platelet counts ranged from 48,000 to 299,000 cells/μl. The peripheral parasite load also varied over a large range, from 2,270 to 400,400 parasites/μl. Clearance of peripheral blood parasites was noted in all patients by 48 h. All patients who presented with coma recovered from coma by 12 h.

View this table:
  • View inline
  • View popup
Table 1

Clinical and laboratory characteristics of children with severe malaria and a subsequent bout of mild malariaa

At the follow-up visit after 1 month, some children manifested mild malaria with symptoms of fever and vomiting. They all had a normal clinical exam. Their peripheral parasitemia ranged from 2+ to 4+ using a semiquantitative system. The hematocrit during this evaluation was nearly double the initial hematocrit level, despite the second infection.

Given that these children had experienced two bouts of P. falciparum malaria with markedly different disease classifications, we wanted to determine whether differences existed in the peripheral blood transcriptional profiles that were associated with mild versus severe disease presentations. Total RNA was extracted from peripheral blood cells collected at each visit and analyzed by microarray. Figure 1 reports the transcripts that had the greatest fold difference between severe and mild samples (paired Students t test, P ≤ 0.05; fold change of ≥2.0). Many of the upregulated genes associated with the mild malaria episode involved the interferon pathway, including IFN-induced protein transcripts (IFIT1 to IFIT3), myxovirus resistance 1 (MX1), oligoadenylate synthetases 1 and 3 (OAS1 and OAS3, respectively), and T cells with upregulation of cathepsin W (CTSW) and perforin 1 (PRF1). The complete list of 68 gene transcripts is given in Table S1 in the supplemental material (P ≤ 0.05). Six genes were associated with severe malaria, including carbonic anhydrase 1 (CA1), G-protein-coupled receptor 89B (GPR89B), lipocalin 2 (LCN2), thymidine kinase 1 (TK1), small nucleolar RNA, C/D box 30 (SNORD30), and TBC1 domain family member 3 (TBC1D3) (P ≤ 0.05; fold change of ≥1.5).

Fig 1
  • Open in new tab
  • Download powerpoint
Fig 1

A heat map of genes associated with mild and severe malaria transcripts significantly differentially abundant between severe and mild presentations is shown (paired Student's t test, P < 0.05; ≥2-fold difference between averages of groups). Many genes associated with mild disease are in the interferon pathway and associated with T cell biology. Data are row normalized.

To identify gene sets upregulated in each clinical state, we employed GSEA (35). Numerous GO functions representing diverse immune processes were upregulated in samples from children during mild malaria. The top pathways are presented in Table 2 (P ≤ 0.001; false-discovery rate [FDR] of <0.01), with a complete list (n = 116) given in Table S2 in the supplemental material (P ≤ 0.001; FDR of <0.05). These GO functions included immune response (GO 0006955), regulation of inflammation (GO 0050727), the type I interferon signaling pathway (GO 0060337), regulation of leukocyte proliferation (GO 00700663), T cell activation (GO 00042110), cell adhesion (GO 007155), and others. The GO functions associated with severe malaria contained G protein-coupled receptor families (GO 0004930; G protein-coupled receptor activity). The high degree of sequence homology of these gene families to GPR89B are consistent with cross-hybridization and thus are not further analyzed.

View this table:
  • View inline
  • View popup
Table 2

Top gene sets enriched in mild malariaa

DISCUSSION

Understanding the factors leading to the acquisition of protection against severe clinical presentations of malaria in areas of endemicity may illuminate new approaches to both prevention and treatment. This is the first report that compares the transcriptomes of peripheral blood cells from children with severe malaria with the transcriptomes of cells from the same children during a subsequent mild malaria infection. These data identify an association of mild malaria with a type I IFN response.

In areas of high transmission, despite episodes of reinfection older children and adults generally suffer only mild or asymptomatic malaria infections and rarely develop severe disease (4, 9). To investigate the mechanism of these field observations and the immune responses associated with variation in disease severity, we carried out a subanalysis on patients enrolled in the Blantyre Malaria Research Project. This study protocol provided an opportunity to identify and study the same children during an episode of severe malaria and, 1 month later, with mild malaria.

During the initial severe disease presentation, the five patients who were part of this study displayed a broad range of abnormal laboratory findings and manifested clinical features characteristic of severe malaria (13, 20). During the second observed infection, patients were dramatically less ill, having no clinical evidence of severe disease. The illness in some was limited to a history of recent fever and vomiting, and they presented with an otherwise normal exam. No complete blood count was done during the outpatient visit, but the semiquantitative estimates of parasitemia revealed high-density parasitemias in several of the children. This may suggest the ability of these patients to mount a more effective host response despite high antigen loads during the mild malaria presentation.

Many of the genes upregulated during the subsequent mild malaria disease were related to the type I IFN pathway. The transcripts OAS1 and OAS3 that were upregulated in mild disease are part of the oligoadenylate synthase family of IFN-induced RNA polymerases (18). Other genes associated with mild disease included IFIT1, IFIT3, and MX1, which are also in the IFN-α/β signaling pathway (Ingenuity Pathway Analysis, version 9.0). The type I interferons IFN-α and IFN-β were originally described as central to effective antiviral immune responses (11). More recently, it has been shown that type I IFNs are also produced in response to Trypanosoma cruzi infection (34, 40). Additionally, a dominant type I IFN signature was identified from whole-blood transcriptional profiling in patients with active Mycobacterium tuberculosis (5).

Genetic studies of malaria-infected patients have found an association between mutations within IFN-α receptor (IFN-αR) and severe disease susceptibility, suggesting that the type I IFN pathway may play a role in severe disease (3, 17). IFN-α has been identified in a subset of malaria-infected patient sera (25, 29). A recent report finds that the mechanism of type I IFN immune induction is through host cell recognition of AT-rich parasite DNA motifs (30). However, the role of type I IFN in protection from severe malaria disease in human studies is unknown. Studies in the rodent model of experimental CM provide conflicting results regarding the role of type I IFN in disease outcomes. Plasmodium berghei ANKA-infected mice treated with 800,000 U of IFN-β demonstrated a 60% improvement in survival compared to untreated mice, without any differences in parasitemia (22). This IFN-β treatment led to reduction in CXCL9 and intracellular adhesion molecule-1 (ICAM-1) transcript levels in the brain, reduction of T-cell CXCR3 expression, and downregulation of serum tumor necrosis factor alpha (TNF-α), suggesting that the anti-inflammatory properties potentially accounted for improved survival. IFN-α has also been demonstrated to have a protective role in the rodent model of severe malaria. Administration of 25 days of IFN-α reduced the CM death rate in C57BL/6 P. berghei ANKA-infected mice from 87% to 6% (41). This protection was associated with reduction in peripheral parasitemia and also reduced upregulation of ICAM-1 expression in brain endothelial cells. In contrast, mice lacking the type I IFN receptor (IFN-αR1−/−) were protected against CM in the P. berghei ANKA model in two studies (15, 30). These conflicting data may be due to the approaches taken; however, they suggest that this pathway is involved in mediating disease outcomes. Our data suggest that the type I IFN pathway is associated with a reduction in disease severity in the P. falciparum-infected human host, but more studies are needed. Identification of plasma α/β cytokines accompanying the type I IFN transcriptional signature during mild malaria would provide further evidence that this pathway is central to the host response during mild malaria infection compared to a severe disease presentation.

Genes and gene sets involved in a T cell response, such as T cell activation (GO 0042110), are also found to be associated with mild malaria. Cytotoxic T lymphocyte (CTL) granules contain perforin and granzyme A (27). These are key effector molecules for CTL-mediated cytolysis, and their transcripts perforin 1 (PRF1) and granzyme A (GZMA) are upregulated in mild malaria. Also upregulated in mild malaria is cathepsin W, a cysteine protease that is expressed in natural killer and CD8+ T cells and is released in target cell killing (33). Studies in the rodent model have identified T cell responses to be important in the liver stage of infection and in the control of the asexual stages (31, 39). Less is known about the role of T cells in human malaria infections. Recently, age-related qualitative differences in the T cell response to merozoite surface protein 1 were shown, which may contribute to age-related malarial immunity (10). Further investigation in the role of T cells in protection from severe disease in humans is needed.

There have been a number of studies that have identified biomarkers associated with severe malaria, including TNF-α, endothelial microparticles, and intracellular adhesion molecule-1, among many others (1). We identified six transcripts to be associated with severe disease, and some of these have been previously been reported in severe malaria. TK1 transcript was associated with severe malaria and was also found to be upregulated in peripheral whole-blood transcriptome in two CM-susceptible strains of mice (C57BL/6 and CBA/CaJ) compared to levels in CM-resistant BALB/c mice (23). Lipocalin 2, also known as human neutrophil lipocalin (HNL), is a component of the innate immune system. It is upregulated and secreted by immune cells after Toll-like receptor recognition of bacteria, with a bacteriostatic effect (12). The association of this transcript with severe malaria is consistent with a study in the Sudan that found plasma concentrations of HNL to be significantly elevated in patients with severe malaria compared to levels in patients with mild malaria (21). These results may lead to the identification of peripheral blood-based biomarkers of severe disease. A diagnostic biomarker would be clinically useful in view of the observation that the clinical diagnosis of CM can be incorrect up to 25% of the time (37).

CA1 was significantly upregulated in children during severe disease. CA1 is primarily expressed in human red blood cells, and one of its major functions is to maintain acid-base homeostasis (19). Acid-base status is often deranged in severe malaria, and four of five children had abnormally high levels of lactate during their severe disease admission (36). The upregulation of CA1 during severe malaria may reflect a host compensatory response to mediate the hyperlactemia. GPR89B was also associated with severe malaria. There are nearly 2,000 G protein-coupled receptor genes which are classified into over 100 subfamilies based on sequence, ligand structure, and function (16). The identification of peripheral blood cells expressing this protein, confirmation of protein expression, and characterization are under way to understand the role of this receptor in severe malaria.

We note that our study has potential limitations. A larger sample size may have facilitated the identification of additional genes or gene sets that are associated with severe malaria infection. The duration of infection at the time of sampling the peripheral blood transcriptomes could have differed between the severe and mild presentations. Children presenting with mild disease may have been studied earlier in the course of infection as they presented for a routine clinic visit which fortuitously detected the second infection, and the host transcriptional profile thus is related to timing of sampling rather than clinical phenotype. Studies of host response at multiple points over time postinfection could differentiate this possibility. Differences in transcriptional signatures can reflect differences in cellular composition or differences in transcript abundance. Peripheral blood contains a heterogeneous mixture of cells, and the two blood samples might differ in their cellular compositions. In a study of blood profiling of Kenyan children with mild malaria, there was a correlation of gene transcription and absolute neutrophil count (14). Thus, cell-specific transcriptomes would further define the host response on a cell phenotype level and could help determine the role of different white cell subsets in pathogenesis. Finally, through a comparison to an uninfected blood transcriptome as a baseline control, we can confirm that gene sets associated with mild malaria represent an upregulation during mild infection rather than a downregulation during severe disease.

Despite these limitations, we observed significant differences between our paired severe/mild transcriptomes. Type I IFN-related pathways and T cell biology were associated with mild malaria infection. The type I interferon data support some of the previously reported studies from animal models, and transcripts associated with severe disease replicate prior severe disease associations. To our knowledge, this is the first study comparing the transcriptional profiles of host peripheral blood cells during severe and subsequent mild disease and provides new paradigms of host response that can be explored to impact severe disease outcomes in malaria.

ACKNOWLEDGMENTS

We thank Viswanathan Lakshmanan and Gregoire Lauvau for critical review of the manuscript and Hongying Jiang for computational analysis.

This work was supported by grants R01 AI077623 and RC1 AI086224 (to J.D.) from the National Institutes of Health.

FOOTNOTES

    • Received 30 September 2011.
    • Returned for modification 29 October 2011.
    • Accepted 19 December 2011.
    • Accepted manuscript posted online 9 January 2012.
  • Supplemental material for this article may be found at http://dx.doi.org/10.1128/IAI.06008-11.

  • Copyright © 2012, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Andrade BB,
    2. Barral-Netto M
    . 2011. Biomarkers for susceptibility to infection and disease severity in human malaria. Mem. Inst. Oswaldo Cruz 106(Suppl 1):70–78.
    OpenUrlPubMed
  2. 2.↵
    1. Aponte JJ,
    2. et al
    . 2007. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 4:e242.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Aucan C,
    2. et al
    . 2003. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 4:275–282.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Baird JK
    . 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today 11:105–111.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Berry MP,
    2. et al
    . 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973–977.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Birbeck GL,
    2. et al
    . 2010. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am. J. Trop. Med. Hyg. 82:231–234.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Boivin MJ,
    2. et al
    . 2010. Developmental outcomes in Malawian children with retinopathy-positive cerebral malaria. Trop. Med. Int. Health 16:263–271.
    OpenUrlPubMed
  8. 8.↵
    1. Breman JG,
    2. Alilio MS,
    3. Mills A
    . 2004. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg. 71:1–15.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Carneiro I,
    2. et al
    . 2010. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 5:e8988.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Chelimo K,
    2. et al
    . 2011. Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS One 6:e24852.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Durbin JE,
    2. et al
    . 2000. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164:4220–4228.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Flo TH,
    2. et al
    . 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917–921.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Grau GE,
    2. et al
    . 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586–1591.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Griffiths MJ,
    2. et al
    . 2005. Genomewide analysis of the host response to malaria in Kenyan children. J. Infect. Dis. 191:1599–1611.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Haque A,
    2. et al
    . 2011. Type I interferons suppress CD4 T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41:2688–2698.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Ji TH,
    2. Grossmann M,
    3. Ji I
    . 1998. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273:17299–17302.
    OpenUrlFREE Full Text
  17. 17.↵
    1. Khor CC,
    2. et al
    . 2007. Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus. Genes Immun. 8:570–576.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Kristiansen H,
    2. Gad HH,
    3. Eskildsen-Larsen S,
    4. Despres P,
    5. Hartmann R
    . 2011. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 31:41–47.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Lindskog S
    . 1997. Structure and mechanism of carbonic anhydrase. Pharmacol. Ther. 74:1–20.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Marsh K,
    2. et al
    . 1995. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 332:1399–1404.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Mohammed AO,
    2. et al
    . 2003. Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria. Acta Tropica 87:279–285.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Morrell CN,
    2. et al
    . 2011. Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun. 79:1750–1758.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Oakley MS,
    2. et al
    . 2011. Molecular correlates of experimental cerebral malaria detectable in whole blood. Infect. Immun. 79:1244–1253.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Ockenhouse CF,
    2. Bernstein WB,
    3. Wang Z,
    4. Vahey MT
    . 2005. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J. Infect. Dis. 191:2064–2074.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Ojo-Amaize EA,
    2. et al
    . 1981. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J. Immunol. 127:2296–2300.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Pankla R,
    2. et al
    . 2009. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10:R127.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Peters PJ,
    2. et al
    . 1991. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173:1099–1109.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Reich M,
    2. et al
    . 2006. GenePattern 2.0. Nat. Genet. 38:500–501.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Rhodes-Feuillette A,
    2. et al
    . 1985. The interferon compartment of the immune response in human malaria: I. Interferon inducers in Plasmodium falciparum cultures. J. Interferon Res. 5:159–168.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Sharma S,
    2. et al
    . 2011. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35:194–207.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Stephens R,
    2. Langhorne J
    . 2010. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog. 6:e1001208.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Stevenson MM,
    2. Riley EM
    . 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169–180.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Stoeckle C,
    2. et al
    . 2009. Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp. Hematol. 37:266–275.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Stryker GA,
    2. Nickell SP
    . 1995. Trypanosoma cruzi: exposure of murine cells to live parasites in vitro leads to enhanced surface class I MHC expression which is type I interferon-dependent. Exp. Parasitol. 81:564–573.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Subramanian A,
    2. et al
    . 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545–15550.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Taylor TE,
    2. Borgstein A,
    3. Molyneux ME
    . 1993. Acid-base status in paediatric Plasmodium falciparum malaria. Q. J. Med. 86:99–109.
    OpenUrlPubMed
  37. 37.↵
    1. Taylor TE,
    2. et al
    . 2004. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10:143–145.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Thach DC,
    2. et al
    . 2005. Surveillance of transcriptomes in basic military trainees with normal, febrile respiratory illness, and convalescent phenotypes. Genes Immun. 6:588–595.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Tsuji M,
    2. Zavala F
    . 2003. T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol. 19:88–93.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Vaena de Avalos S,
    2. Blader IJ,
    3. Fisher M,
    4. Boothroyd JC,
    5. Burleigh BA
    . 2002. Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 277:639–644.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Vigario AM,
    2. et al
    . 2007. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 178:6416–6425.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    WHO. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2006/9241546948_eng.pdf.
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Mild Plasmodium falciparum Malaria following an Episode of Severe Malaria Is Associated with Induction of the Interferon Pathway in Malawian Children
Malkie Krupka, Karl Seydel, Catherine M. Feintuch, Kenny Yee, Ryung Kim, Chang-Yun Lin, R. Brent Calder, Christine Petersen, Terrie Taylor, Johanna Daily
Infection and Immunity Feb 2012, 80 (3) 1150-1155; DOI: 10.1128/IAI.06008-11

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mild Plasmodium falciparum Malaria following an Episode of Severe Malaria Is Associated with Induction of the Interferon Pathway in Malawian Children
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mild Plasmodium falciparum Malaria following an Episode of Severe Malaria Is Associated with Induction of the Interferon Pathway in Malawian Children
Malkie Krupka, Karl Seydel, Catherine M. Feintuch, Kenny Yee, Ryung Kim, Chang-Yun Lin, R. Brent Calder, Christine Petersen, Terrie Taylor, Johanna Daily
Infection and Immunity Feb 2012, 80 (3) 1150-1155; DOI: 10.1128/IAI.06008-11
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522